Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins

Molecular and Cellular Biology

Volumn 26, Issue 7, 2006, Pages 2467-2478

  Kim, Sungeun ^a   Denny, Christopher T ^b   Wisdom, Ron ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Research Building III ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EWS ETS FUSION PROTEIN; HYBRID PROTEIN; PROTEIN; PROTEIN ERG; PROTEIN ETV1; PROTEIN FLI1; PROTEIN FOS; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; URIDINE PHOSPHORYLASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL STRAIN 3T3; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; EMBRYO; EWING SARCOMA; FIBROBLAST; GENE MUTATION; HUMAN; MOUSE; NONHUMAN; ONCOGENE RAS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALS; BINDING SITES; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DNA; GENE EXPRESSION REGULATION; MICE; MUTATION; NIH 3T3 CELLS; ONCOGENE PROTEINS, FUSION; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEIN C-FLI-1; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RESPONSE ELEMENTS; RNA-BINDING PROTEIN EWS; TRANSCRIPTION FACTOR AP-1;

ANIMALIA;

EID: 33645237099     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.26.7.2467-2478.2006     Document Type: Article

References (36)

1. Arvand, A., and C. T. Denny. 2001. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20:5747-5754.
2. Arvand, A., S. M. Welford, M. A. Teitell, and C. T. Denny. 2001. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1. Cancer Res. 61:5311-5317.
3. Bartel, F. O., T. Higuchi, and D. D. Spyropoulos. 2000. Mouse models in the study of the Ets family of transcription factors. Oncogene 19:6443-6454.
4. Bosc, D. G., B. S. Goueli, and R. Janknecht. 2001. Her2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene 20:6215-6224.
5. Chen, L., J. N. Glover, P. G. Hogan, A. Rao, and S. C. Harrison. 1998. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 392:42-48.
6. Delattre, O., J. Zucman, B. Ploufastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jong, G. Rouleau, et al. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumors. Nature 359:162-165.
7. Deneen, B., H. Hamidi, and C. T. Denny. 2003. Functional analysis of the EWS/ETS target gene uridine phosphorylase. Cancer Res. 63:4268-4274.
8. Escalante, C. R., A. L. Brass, J. M. Pongubala, E. Shatova, L. Shen, H. Singh, and A. Aggarwal. 2002. Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol. Cell 10:1097-1105.
9. Foos, G., J. J. Garcia-Ramirez, C. K. Galang, and C. A. Hauser. 1998. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation. J. Biol. Chem. 273:18871-18880.
10. Fu, S., I. Bottoli, M. Goller, and P. K. Vogt. 1999. Heparin-binding epidermal growth factor-like growth factor, a v-Jun target gene, induces oncogenic transformation. Proc. Natl. Acad. Sci. USA 96:5716-5721.
11. Garvie, C. W., J. Hagman, and C. Wolberger. 2001. Structural studies of Ets-1/Pax5 complex formation on DNA. Mol. Cell 8:1267-1276.
12. Goetz, T. L., T.-L. Gu, N. A. Speck, and B. J. Graves. 2000. Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor α2. Mol. Cell. Biol. 20:81-90.
13. Graves, B. J., and J. M. Petersen. 1998. Specificity within the ets family of transcription factors. Adv. Cancer Res. 75:1-55.
14. Hassler, M., and T. J. Richmond. 2001. The B-box dominates SAP-1-SRF interactions in the structure of the ternary complex. EMBO J. 20:3018-3028.
15. Hever, A., R. G. Oshima, and C. A. Hauser. 2003. Ets2 is not required for Ras or Neu/ErbB-2 mediated cellular transformation in vitro. Exp. Cell Res. 290:132-143.
16. Hill, C. S., R. Marais, S. John, J. Wynne, S. Dalton, and R. Treisman. 1993. Functional analysis of a growth factor-responsive transcription factor complex. Cell 73:395-406.
17. Hollenhorst, P. C., D. A. Jones, and B. J. Graves. 2004. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res. 32:5693-5702.
18. Janknecht, R. 1996. Analysis of the ERK-stimulated transcription factor ER81. Mol. Cell. Biol. 16:1550-1556.
19. Johnson, I. M., H. J. Spence, J. N. Winnie, L. McGarry, J. K. Vass, L. Meagher, G. Stapleton, and B. W. Ozanne. 2000. Regulation of a multigenic expression programmed by the transcription factor, AP-1: re-expression of a down-regulated gene, TSC-36, inhibits invasion. Oncogene 19:5348-5358.
20. Langer, S. J., D. M. Bortner, M. F. Roussel, C. J. Sherr, and M. C. Ostrowski. 1992. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. Mol. Cell. Biol. 12:5355-5362.
21. Louie, M. C., H. Q. Yang, A. H. Ma, W. Xu, J. X. Zou, H. J. Kung, and H. W. Chen. 2003. Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc. Natl. Acad. Sci. USA 100:2226-2230.
22. Mao, X., S. Miesfeldt, H. Yang, J. M. Leiden, and C. B. Thompson. 1994. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J. Biol. Chem. 269:18216-18222.
23. May, W. A., M. L. Gishizky, S. L. Lessnick, L. B. Sunsford, B. C. Lewis, O. Delattre, J. Zucman, G. Thomas, and C. T. Denny. 1993. Ewing sarcoma 11:22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc. Natl. Acad. Sci. USA 90:5752-5756.
24. McCarthy, S. A., D. Chen, B. S. Yang, J. J. Garcia Ramirez, H. Cherwinski, X. R. Chen, M. Klagsbrun, C. A. Hauser, M. C. Ostrowski, and M. McMahon. 1997. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1. Mol. Cell. Biol. 17:2401-2412.
25. McGarry, L. C., J. N. Winnie, and B. W. Ozanne. 2004. Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes. Oncogene 23:5284-5292.
26. Ordway, J. M., K. Williams, and T. Curran. 2004. Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1. Oncogene 23:3737-3748.
27. Peterson, B. R., L. J. Sun, and G. L. Verdine. 1996. A critical arginine residue mediates cooperativity in the contact interface between transcription factors NFAT and AP-1. Proc. Natl. Acad. Sci. USA 94:13671-13676.
28. Pufall, M. A., and B. J. Graves. 2002. Autoinhibitory domains: modular effectors of cellular regulation. Annu. Rev. Cell Dev. Biol. 18:421-462.
29. Pufall, M. A., G. M. Lee, M. L. Nelson, H. S. Kang, A. Velyvis, L. E. Kay, L. P. McIntosh, and B. J. Graves. 2005. Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region. Science 309:142-145.
30. Sprowles, A., and R. Wisdom. 2003. Oncogenic effect of delta deletion in v-Jun does not result from uncoupling Jun from JNK signaling. Oncogene 22:498-506.
31. Thompson, A. D., M. A. Teitell, A. Arvand, and C. T. Denny. 1999. Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells. Oncogene 18:5506-5513.
32. Treisman, R., R. Marais, and J. Wynne. 1992. Spatial flexibility in ternary complexes between SRF and its accessory proteins. EMBO J. 11:4631-4640.
33. Ullman, K. S., J. P. Northrop, A. Admon, and G. R. Crabtree. 1993. Jun family members are controlled by a calcium-regulated, cyclosporin A-sensitive signaling pathway in activated T lymphocytes. Genes Dev. 7:188-196.
34. Wisdom, R., R. S. Johnson, and C. Moore. 1999. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J. 18:188-197.
35. Wisdom, R., L. Huynh, D. Hsia, and S. Kim. 2005. Ras and TGF-b exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation. Oncogene 24:7043-7054.
36. Yang, B. S., C. A. Hauser, G. Henkel, M. S. Colman, C. van Beveren, K. J. Stacey, D. A. Hume, R. A. Maki, and M. C. Ostrowski. 1996. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16:538-547.